<p>The UC San Diego Chronic Lymphocytic Leukemia Study is designed to identify genetic, epigenetic, and transcriptional changes important for CLL. This data release consists of samples collected to 1) identify genomic changes associated with CLL progression using serially collected tumor samples; 2) characterize the transcriptional consequences of SF3B1 mutation through RNA-seq; and 3) characterize the expression profiles of ROR1+ vs. ROR1- tumors. The samples were collected from participants at the University of California, San Diego Moores Cancer Center and the data was generated at UC San Diego or in collaboration with the BC Cancer Agency Genome Sciences Centre.</p>

The UC San Diego Chronic Lymphocytic Leukemia (CLL) Study

Leukemia, Lymphocytic, Chronic, B-Cell study with AMPLICON, RNA-Seq data on dbGaP (49 participants)

The UC San Diego Chronic Lymphocytic Leukemia (CLL) Study

Description

Applying For Access

Summary